IL-13

dupixent

Sanofi pumps up Dupixent and other respiratory pipeline drugs

Sanofi is touting the advantages of Dupixent in COPD, along with the prospects of its other pipeline treatments for respiratory disorders.

Kevin Dunleavy May 22, 2023 11:00am

COPD

COPD trial data coming soon for Sanofi, Regneron’s Dupixent

Mar 20, 2023 8:34am

Valeant

Valeant undercuts psoriasis rivals with $3,500 Siliq price

Apr 21, 2017 9:37am

Dupixent package

Amgen slaps Sanofi, Regeneron with Dupixent lawsuit

Apr 20, 2017 8:37am